Pharmacist Follow-up, a Qualitative Study of Patient Experience
Pharmacist Follow-up of Patients With Coronary Heart Disease. A Qualitative Study of Patient Experience.
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Tromso, Norway, 9037
- University of Tromsoe
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- must have met the pharmacist at least twice
- living within the area of Tromsoe city so that interviews are possible
Exclusion Criteria
- none as patients are already enrolled in another study
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
Study group
Patients who are included in the pharmacist follow-up procedure
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Qualitative evaluation of the impact of pharmacist follow-up via interviews with the participating patients
Time Frame: 3 months or 1 year
|
In the pharmacist follow-up procedure under development, patients have individual "consultations" with a pharmacist three times.
Patients are recruited to this study at the second or third consultation.
Interviews will be performed with patients included to explore how patients' experience this follow-up procedure.
Outcome measures from patient interviews can be counted.
In qualitative research, the content of the interviews are thoroughly analysed with focus on the meaning of the informant's/interviewee's sayings.
Outcomes will be presented as overall themes touched by the informants.
|
3 months or 1 year
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Lars Smaabrekke, PhD, University of Tromso
- Study Chair: Beate H Garcia, PhD, Hospital Pharmacy of North Norway Trust
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- SHAN-002
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.